NEW YORK, March 24 (GenomeWeb News) - MWG Biotech will supply Pfizer with sequencing services, microarrays, and oligonucleotides, the company said today.

 

Under a new worldwide framework agreement, MWG Biotech of Ebersberg, Germany, will be Pfizer's "Partner of Choice" for these products and services. The agreement is non-exclusive and unlimited, according to an MWG spokeswoman.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Technology Review reports that researchers in the US have used CRISPR to modify a number of human embryos.

By introducing genes from butterfly peas and Canterbury bells, researchers in Japan have developed a blue chrysanthemum, according to NPR.

Plant researchers plan to sequence some 10,000 samples that represent the major plant clades, ScienceInsider reports.

In Nature this week: a Danish reference genome, and more.